| 23rd Apr 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Apr 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 22nd Apr 2020 10:11 am |
RNS |
EAACI review of adjuvants and formulations |
| 1st Apr 2020 1:09 pm |
RNS |
Grant and Vesting of Awards |
| 9th Mar 2020 7:15 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Consistent first-half revenue growth |
| 4th Mar 2020 7:00 am |
RNS |
Half-year Report |
| 29th Jan 2020 12:00 pm |
RNS |
Data for peanut allergy vaccine published in JACI |
| 16th Jan 2020 12:25 pm |
RNS |
Trading Update & Notice of Results - Replacement |
| 16th Jan 2020 8:00 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Sales growth well above market average |
| 16th Jan 2020 7:00 am |
RNS |
Half Year Trading Update & Notice of Results |
| 2nd Dec 2019 9:57 am |
RNS |
Holdings in Company |
| 29th Nov 2019 10:34 am |
RNS |
Holdings in Company |
| 26th Nov 2019 7:00 am |
RNS |
Update to Grass MATA MPL Ph III clinical programme |
| 25th Nov 2019 12:13 pm |
RNS |
Result of Annual General Meeting |
| 22nd Oct 2019 9:23 am |
RNS |
Annual Report and Accounts |
| 26th Sep 2019 7:30 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Continuing to gain market share |
| 25th Sep 2019 7:00 am |
RNS |
Preliminary Results |
| 11th Jul 2019 7:00 am |
RNS |
Trading update |
| 1st Jul 2019 7:21 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Successful legal outcome removes uncertainty |
| 1st Jul 2019 7:16 am |
EQS |
Hardman & Co Research: Oxford BioMedica (OXB): Eying up long-term value |
| 27th Jun 2019 7:00 am |
RNS |
Successful Litigation Settlement |
| 27th Jun 2019 7:00 am |
RNS |
Trading Statement |
| 19th Jun 2019 7:00 am |
RNS |
Board Change |
| 11th Jun 2019 7:00 am |
RNS |
Holdings in Company |
| 21st May 2019 7:15 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): House dust mite vaccine - clinical progress |
| 20th May 2019 7:00 am |
RNS |
Positive top line phase I results for Acarovac MPL |
| 14th May 2019 7:00 am |
RNS |
Holdings in Company |
| 13th May 2019 6:14 pm |
RNS |
Holding(s) in Company |
| 13th May 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 13th May 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 7th May 2019 7:00 am |
RNS |
Research Published on Adjuvant Systems |
| 25th Apr 2019 7:00 am |
RNS |
Regulatory and Trading Update |
| 18th Mar 2019 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 18th Mar 2019 4:36 pm |
RNS |
Price Monitoring Extension |
| 18th Mar 2019 11:30 am |
EQS |
Hardman & Co Research: Allergy Therapeutics (AGY): Take an objective view |
| 18th Mar 2019 11:05 am |
RNS |
Second Price Monitoring Extn |
| 18th Mar 2019 11:00 am |
RNS |
Price Monitoring Extension |
| 18th Mar 2019 9:05 am |
RNS |
Second Price Monitoring Extn |
| 18th Mar 2019 9:00 am |
RNS |
Price Monitoring Extension |
| 18th Mar 2019 7:00 am |
RNS |
Top Line Phase III results from B301 trial |
